Defer-struc-01.jpg (Defer Struc 01)
Chemical structure of DEFEROXAMINE MESYLATE, showing its molecular arrangement including functional groups and bonding.*
Deferoxamine Injection, Powder, Lyophilized, For Solution
Product Images NDC 63323-597
6 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Deferoxamine (NDC 63323-597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Defer-img-01.jpg (Defer Img 01)
Defer-label-01.jpg (Defer Label 01)
Deferoxamine Mesylate for Injection, USP powder vial label showing 500 mg per vial strength. The label states it is for subcutaneous, intramuscular, or intravenous use. It is a single-dose vial, sterile, and Rx only. The label includes storage instructions (20°C to 25°C) and notes the vial closure is not made with natural rubber latex. The labeler is Fresenius Kabi USA, LLC.*
Defer-label-02.jpg (Defer Label 02)
Label for Deferoxamine Mesylate for Injection, USP, 500 mg per vial, lyophilized powder for solution. The label indicates administration routes as subcutaneous, intramuscular, or intravenous and includes storage instructions (20°C to 25°C). Labeler is Fresenius Kabi USA, LLC. The package is for a single-dose vial and includes barcode and regulatory information.*
Defer-label-03.jpg (Defer Label 03)
Label for Deferoxamine Mesylate injection, USP, 2 grams per vial, lyophilized powder for solution. The vial is single-dose, intended for subcutaneous, intramuscular, or intravenous use. Label includes storage instructions at 20°C to 25°C and manufacturer information: Fresenius Kabi USA, LLC.*
Defer-label-04.jpg (Defer Label 04)
Label for Deferoxamine Mesylate for Injection, USP, 2 grams per vial, lyophilized powder for solution, by Fresenius Kabi USA, LLC. The label includes dosing form, vial size, storage instructions, and administration routes (subcutaneous, intramuscular, intravenous). It features the NDC 63323-599-30 and the Fresenius Kabi logo.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
